Login to Your Account



United Therapeutics Subsidiary Gets Potential $45M Contract

By Tom Wall


Tuesday, October 11, 2011
Unither Virology LLC, a subsidiary of United Therapeutics Corp., won a potential $45 million contract from the National Institutes of Health (NIH) for preclinical studies of an antiviral glycobiology drug candidate to treat viruses such as dengue and influenza.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription